Evidence map›Paper›PMID 34479643›Full record

ArticleGenome medicine2021

Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK.

Samuel Lipworth, Karina-Doris Vihta, Kevin Chau, Leanne Barker, Sophie George, James Kavanagh, Timothy Davies, Alison Vaughan, Monique Andersson, Katie Jeffery and 7 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular epidemiology of Klebsiella pneumoniae causing bloodstream infections in a district hospital in Northern Portugal (2016-2018): clonal diversity and detection of hypervirulent strains.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Genomic epidemiology of third-generation cephalosporin-resistantOne health (Amsterdam, Netherlands) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Samuel LipworthNuffield Department of Medicine, University of Oxford, Oxford, UK. Samuel.lipworth@ndm.ox.ac.uk.ORCID 0000-0001-5872-9214
Karina-Doris VihtaNuffield Department of Medicine, University of Oxford, Oxford, UK.
Kevin ChauNuffield Department of Medicine, University of Oxford, Oxford, UK.
Leanne BarkerNuffield Department of Medicine, University of Oxford, Oxford, UK.
Sophie GeorgeNuffield Department of Medicine, University of Oxford, Oxford, UK.
James KavanaghNuffield Department of Medicine, University of Oxford, Oxford, UK.
Timothy DaviesNuffield Department of Medicine, University of Oxford, Oxford, UK.
Alison VaughanNuffield Department of Medicine, University of Oxford, Oxford, UK.
Monique AnderssonOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Katie JefferyOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Sarah OakleyOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Marcus MorganOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Susan HopkinsNational Infection Service, Public Health England, Colindale, London, UK.
Timothy E A PetoNuffield Department of Medicine, University of Oxford, Oxford, UK.
Derrick W CrookNuffield Department of Medicine, University of Oxford, Oxford, UK.
Ann Sarah Walker *Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nicole Stoesser *Nuffield Department of Medicine, University of Oxford, Oxford, UK.
University of Oxford · GBOxford University Hospitals NHS Trust · GBPublic Health England · GBJohn Radcliffe Hospital · GB

Funding

Department of Health NIHR200915Medical Research Council MR/T001151/1MRF_ MRF-145-0004-TPG-AVISOWellcome TrustWellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

backgroundThe incidence of Gram-negative bloodstream infections (BSIs), predominantly caused by Escherichia coli and Klebsiella species, continues to increase; however, the causes of this are unclear and effective interventions are therefore hard to design.

methodsIn this study, we sequenced 3468 unselected isolates over a decade in Oxfordshire (UK) and linked this data to routinely collected electronic healthcare records and mandatory surveillance reports. We annotated genomes for clinically relevant genes, contrasting the distribution of these within and between species, and compared incidence trends over time using stacked negative binomial regression.

resultsWe demonstrate that the observed increases in E. coli incidence were not driven by the success of one or more sequence types (STs); instead, four STs continue to dominate a stable population structure, with no evidence of adaptation to hospital/community settings. Conversely in Klebsiella spp., most infections are caused by sporadic STs with the exception of a local drug-resistant outbreak strain (ST490). Virulence elements are highly structured by ST in E. coli but not Klebsiella spp. where they occur in a diverse spectrum of STs and equally across healthcare and community settings. Most clinically hypervirulent (i.e. community-onset) Klebsiella BSIs have no known acquired virulence loci. Finally, we demonstrate a diverse but largely genus-restricted mobilome with close associations between antimicrobial resistance (AMR) genes and insertion sequences but not typically specific plasmid replicon types, consistent with the dissemination of AMR genes being highly contingent on smaller mobile genetic elements (MGEs).

conclusionsOur large genomic study highlights distinct differences in the molecular epidemiology of E. coli and Klebsiella BSIs and suggests that no single specific pathogen genetic factors (e.g. AMR/virulence genes/sequence type) are likely contributing to the increasing incidence of BSI overall, that association with AMR genes in E. coli is a contributor to the increasing number of E. coli BSIs, and that more attention should be given to AMR gene associations with non-plasmid MGEs to try and understand horizontal gene transfer networks.

Indexed as

Molecular EpidemiologyAnti-Bacterial AgentsBacteremiaDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsHumansIncidenceKlebsiellaKlebsiella InfectionsKlebsiella pneumoniaeLongitudinal StudiesPlasmidsSepsisUnited KingdomVirulenceAnti-Bacterial AgentsAntimicrobial resistanceBacteraemiaGram-negative bloodstream infectionsVirulenceWhole genome sequencing, Klebsiella pneumoniae

Identifiers

PMID34479643
PMCPMC8414751
OpenAlexW3191831294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.